E J Bloom
Overview
Explore the profile of E J Bloom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
260
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dhar S, Pressman G, Subramanian S, Kaul S, Gollamudi S, Bloom E, et al.
Postgrad Med J
. 2009 Jun;
85(1004):299-302.
PMID: 19528304
Natriuretic peptides such as brain natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP) are commonly used in the diagnosis and evaluation of heart failure. However, their utility in patients with chronic...
2.
Shekhter-Levin S, Bloom E, Swerdlow S, Sherer M, Wald N, Gollin S
Cancer Genet Cytogenet
. 1997 Jun;
95(2):190-7.
PMID: 9169040
Two years after a bone marrow transplant (BMT) from his haploidentical mother, a 28-year-old male with a history of acute lymphoblastic leukemia (ALI.) developed myelodysplastic syndrome (MDS) with monosomy 7...
3.
Jonnalagadda V, Bloom E, Raja R
Adv Perit Dial
. 1997 Jan;
13:113-5.
PMID: 9360662
There is a great variation in erythropoietin (rHuEPO) requirements in peritoneal dialysis (PD) patients. Although some studies show the importance of higher iron saturation (FeS, > 20%) in hemodialysis patients...
4.
Richert S, Bloom E, Flynn K, Seraly M
J Am Acad Dermatol
. 1996 Aug;
35(2 Pt 2):326-9.
PMID: 8698918
Eruptive nevi have been associated with local skin trauma and immunosuppression, and atypical eruptive nevi preceding melanoma have been reported in immunocompromised transplant patients. We describe a 25-year-old man with...
5.
deMagalhaes-Silverman M, Rybka W, Lembersky B, Bloom E, Lister J, Pincus S, et al.
Am J Clin Oncol
. 1996 Apr;
19(2):169-73.
PMID: 8610643
This study was designed to establish the toxicity and response rates o observed with a combination of high-dose cyclophosphamide, carboplatin, and etoposide with stem cell rescue in patients with breast...
6.
deMagalhaes-Silverman M, Bloom E, Donnenberg A, Lister J, Pincus S, Rybka W, et al.
Bone Marrow Transplant
. 1996 Mar;
17(3):329-33.
PMID: 8704682
Between July 1991 and January 1994, 52 patients with hematologic malignancies underwent BMT using BU/CY2 as conditioning regimen. Median patient age was 38 years. Eleven patients underwent autologous BMT, 22...
7.
Schwinghammer T, Bloom E, Rosenfeld C, Wilson J, Przepiorka D, Shadduck R
Bone Marrow Transplant
. 1995 Jul;
16(1):147-54.
PMID: 7581115
Twenty-eight consecutive recipients of HLA-identical sibling marrow grafts received prophylaxis for GVHD with high-dose cyclosporine (CsA) and corticosteroids. CsA 5 mg/kg/day (2.5 mg/kg infused over 4 h twice daily) was...
8.
Lister J, Rybka W, Donnenberg A, deMagalhaes-Silverman M, Pincus S, Bloom E, et al.
Clin Cancer Res
. 1995 Jun;
1(6):607-14.
PMID: 9816022
Relapse after high-dose chemotherapy supported by peripheral blood stem cell transplantation (HDC-PBSCT) is the main cause of therapeutic failure in patients with lymphoma and breast cancer. Adoptive immunotherapy with activated...
9.
Memon M, deMagalhaes-Silverman M, Bloom E, Lister J, Myers D, Pincus S, et al.
Bone Marrow Transplant
. 1995 Feb;
15(2):283-6.
PMID: 7773219
We report the occurrence of reversible cyclosporine-induced cortical blindness in three allogeneic bone marrow transplant recipients. Possible mechanisms involved in this rare complication, as well as the associated radiographic and...
10.
Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation
Schwinghammer T, Bloom E
Clin Pharm
. 1993 Oct;
12(10):736-61.
PMID: 8258255
The immunology, pathophysiology, incidence, clinical manifestations, grading, and prevention of acute graft-versus-host disease (GVHD) are reviewed. GVHD occurs after allogeneic marrow transplantation when immunologically competent T lymphocytes in the donor...